780 related articles for article (PubMed ID: 34091115)
1. Establishment and validation of immune microenvironmental gene signatures for predicting prognosis in patients with head and neck squamous cell carcinoma.
Wang J; Tian Y; Zhu G; Li Z; Wu Z; Wei G; Zhuang L; Li Z; Chen X; Zhang X; Zheng J; Cai G
Int Immunopharmacol; 2021 Aug; 97():107817. PubMed ID: 34091115
[TBL] [Abstract][Full Text] [Related]
2. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
[No Abstract] [Full Text] [Related]
3. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma.
Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J
BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a novel ferroptosis-related gene signature for predicting prognosis and immune microenvironment in head and neck squamous cell carcinoma.
He F; Chen Z; Deng W; Zhan T; Huang X; Zheng Y; Yang H
Int Immunopharmacol; 2021 Sep; 98():107789. PubMed ID: 34130150
[TBL] [Abstract][Full Text] [Related]
5. Identification novel prognostic signatures for Head and Neck Squamous Cell Carcinoma based on ceRNA network construction and immune infiltration analysis.
Zhou H; He Y; Li L; Wu C; Hu G
Int J Med Sci; 2021; 18(5):1297-1311. PubMed ID: 33526991
[No Abstract] [Full Text] [Related]
6. An Immune-Related Gene Prognostic Index for Head and Neck Squamous Cell Carcinoma.
Chen Y; Li ZY; Zhou GQ; Sun Y
Clin Cancer Res; 2021 Jan; 27(1):330-341. PubMed ID: 33097495
[TBL] [Abstract][Full Text] [Related]
7. Identification of Immune-Related Prognostic Biomarkers Associated with HPV-Positive Head and Neck Squamous Cell Carcinoma.
Chen Y; Nie J; Li X; Fan T; Deng X; Liang D; Song G
J Immunol Res; 2021; 2021():6661625. PubMed ID: 33506058
[TBL] [Abstract][Full Text] [Related]
8. CELSR3 is a prognostic marker in HNSCC and correlates with immune cell infiltration in the tumor microenvironment.
Wu Z; Zhu Z; Wu W; Hu S; Cao J; Huang X; Xie Q; Deng C
Eur Arch Otorhinolaryngol; 2024 Jun; 281(6):3143-3156. PubMed ID: 38507078
[TBL] [Abstract][Full Text] [Related]
9. A novel comprehensive immune-related gene signature as a promising survival predictor for the patients with head and neck squamous cell carcinoma.
Fang R; Iqbal M; Chen L; Liao J; Luo J; Wei F; Wen W; Sun W
Aging (Albany NY); 2021 Apr; 13(8):11507-11527. PubMed ID: 33867351
[TBL] [Abstract][Full Text] [Related]
10. Immune Infiltration-Related ceRNA Network Revealing Potential Biomarkers for Prognosis of Head and Neck Squamous Cell Carcinoma.
Zhao S; Peng M; Wang Z; Cao J; Zhang X; Yu R; Huang T; Lian W
Dis Markers; 2022; 2022():1014347. PubMed ID: 36097539
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma.
Mito I; Takahashi H; Kawabata-Iwakawa R; Ida S; Tada H; Chikamatsu K
Sci Rep; 2021 Aug; 11(1):16134. PubMed ID: 34373557
[TBL] [Abstract][Full Text] [Related]
12. Establishment and validation of a tumor-infiltrating γδT cell related prognostic gene signature in head and neck squamous cell carcinoma.
Lu Y; Xiang Z; Wang W; Yun B; Yi C; Zhang M; Xie N; Wang C; Zhuang Z
Int Immunopharmacol; 2024 May; 132():112054. PubMed ID: 38608477
[TBL] [Abstract][Full Text] [Related]
13. High expression of CLEC10A in head and neck squamous cell carcinoma indicates favorable prognosis and high-level immune infiltration status.
Zou M; Wu H; Zhou M; Xiao F; Abudushalamu G; Yao Y; Zhao F; Gao W; Yan X; Fan X; Wu G
Cell Immunol; 2022 Feb; 372():104472. PubMed ID: 35093731
[TBL] [Abstract][Full Text] [Related]
14.
Chen L; Lin J; Lan B; Xiong J; Wen Y; Chen Y; Chen CB
Comput Math Methods Med; 2022; 2022():5851755. PubMed ID: 36510584
[TBL] [Abstract][Full Text] [Related]
15. The prognostic value of TMB and the relationship between TMB and immune infiltration in head and neck squamous cell carcinoma: A gene expression-based study.
Zhang L; Li B; Peng Y; Wu F; Li Q; Lin Z; Xie S; Xiao L; Lin X; Ou Z; Cai T; Rong H; Fan S; Li J
Oral Oncol; 2020 Nov; 110():104943. PubMed ID: 32919362
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
Zhang F; Liu Y; Yang Y; Yang K
BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
[TBL] [Abstract][Full Text] [Related]
17. Screening the key genes of prognostic value in the microenvironment for head and neck squamous cell carcinoma.
Meng D; Liu T; Ma F; Wang M
Medicine (Baltimore); 2021 Jan; 100(4):e24184. PubMed ID: 33530209
[TBL] [Abstract][Full Text] [Related]
18. A novel immune-related long non-coding RNA signature improves the prognosis prediction in the context of head and neck squamous cell carcinoma.
Chen L; Cai Z; Lyu K; Cai Z; Lei W
Bioengineered; 2021 Dec; 12(1):2311-2325. PubMed ID: 34167440
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive characterization of the tumor microenvironment for assessing immunotherapy outcome in patients with head and neck squamous cell carcinoma.
Zhang J; Zhong X; Jiang H; Jiang H; Xie T; Tian Y; Li R; Wang B; Zhang J; Yuan Y
Aging (Albany NY); 2020 Nov; 12(22):22509-22526. PubMed ID: 33216727
[TBL] [Abstract][Full Text] [Related]
20. Identification and analysis of genes associated with head and neck squamous cell carcinoma by integrated bioinformatics methods.
Jin Y; Yang Y
Mol Genet Genomic Med; 2019 Aug; 7(8):e857. PubMed ID: 31304688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]